Meet Ipsen in the US

Welcome, take a look around and learn more about us.

Our mission?

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care.

Our passion drives our commitment to patients living with difficult-to-treat diseases, and we put them first. Because patients are our priority, we help them through our expertise in oncology, neuroscience, and rare diseases.

We bring medicines to patients with the strength of nearly 6,000 employees across the globe, including innovators in our key therapeutic areas.

Download our annual report

About

“How do we bring transformative medicines to patients? Our North American headquarters in Cambridge’s Kendall Square is the center for tapping into the best talent and partnerships—it’s where the newest thinking in biotech happens. Our network of shared labs and facilities in Kendall Square and Basking Ridge, NJ, spurs our people to do their best thinking.”


Richard Paulson, Chief Executive Officer - Ipsen North America

Oncology

Our oncology work focuses on solid tumors and some of the hardest-to-treat cancers. We power a growing portfolio of therapies aimed at improving the lives of patients with gastrointestinal and pancreatic neuroendocrine tumors, carcinoid syndrome, and pancreatic cancer.

Neuroscience

People suffering from neurological disorders are in need of treatments, and we’ve become a global leader in creating them through the research, development, manufacturing and commercialization of neurotoxins to help treat certain types of spasticity in adults and children two years and older, and cervical dystonia in adults.

Rare diseases

We continue to evolve and grow our research efforts in the area of rare and ultra-rare diseases. Given the limited understanding of these diseases, we are committed to addressing patient needs, from supporting diagnosis to treatment with specific investment in pituitary pathologies, growth disorders, and ultra-rare bone diseases, including fibrodysplasia ossificans progressiva, commonly known as FOP.

Clinical Trials

Clinical trials can lead to medical outcomes that help improve lives, and we thank all of our patients who make this critical research possible through their participation in trials. If you would like to learn more about enrolling in a study, visit clinicaltrials.gov.

Every year our employees in the United States participate in a Day of Service, focusing on—and working side-by-side with—organizations that help lift up our local communities.

Throughout the year, we participate in other events to raise awareness of the diseases that impact the patients we serve.

©2020 Ipsen Biopharmaceuticals, Inc. All rights reserved. June 2020 MP-US-000472